Death receptor 5 and neuroproliferation

Cellular and Molecular Neurobiology

Volumn 32, Issue 2, 2012, Pages 255-265

  Niu, Yanli ^a   Li, Yongqiang ^a   Zang, Jianfeng ^a   Huang, Hongen ^b   Deng, Jiexin ^a   Cui, Zhanjun ^a   Yu, Dongming ^a   Deng, Jinbo ^a  

^a HENAN UNIVERSITY   (China)

^b Jiujiang Traditional Hospital   (China)

Author keywords

BrdU; Cerebellum; Dentate gyrus; Development; DR5; Neurogenesis

Indexed keywords

DEATH RECEPTOR 5; DOUBLECORTIN; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CEREBELLUM; CONTROLLED STUDY; DENTATE GYRUS; DEVELOPMENTAL STAGE; EMBRYO; FEMALE; GRANULAR CELL; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STEM CELL; SUBVENTRICULAR ZONE; TISSUE DISTRIBUTION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CEREBELLUM; DENTATE GYRUS; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; INTESTINE, SMALL; MALE; MICE; MICE, INBRED C57BL; NEURAL STEM CELLS; NEURONS; OLFACTORY BULB; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84864718231     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-011-9757-3     Document Type: Article

References (50)

1. Abdulghani J, El-Deiry WS (2010) TRAIL receptor signaling and therapeutics. Expert Opin Ther Targets 14:1091-1108
2. Aguirre A, Rubio ME, Gallo V (2010) Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal. Nature 467:323-327
3. Alcock J, Scotting P, Sottile V (2007) Bergmann glia as putative stem cells of the mature cerebellum. Med Hypotheses 69:341-345
4. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305-1308
5. Bai X, Williams JL, Greenwood SL, Baker PN, Aplin JD, Crocker IP (2009) A placental protective role for trophoblast-derived TNFrelated apoptosis-inducing ligand (TRAIL). Placenta 30:855-860
6. Bellail AC, Qi L, Mulligan P, Chhabra V, Hao C (2009) TRAIL agonists on clinical trials for cancer therapy: the promises and the challenges. Rev Recent Clin Trials 4:34-41
7. Belyanskaya LL, Ziogas A, Hopkins-Donaldson S, Kurtz S, Simon HU, Stahel R, Zangemeister-Wittke U (2008) TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8. Lung Cancer 60:355-365
8. Bisson I, Prowse DM (2009) WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 19:683-697
9. Brand AH, Livesey FJ (2011) Neural stem cell biology in vertebrates and invertebrates: more alike than different? Neuron 70:719-729
10. Buchsbaum DJ, Forero-Torres A, LoBuglio AF (2007) TRAIL receptor antibodies as a potential cancer treatment. Future Oncol 3:405-409
11. Budd RC (2002) Death receptors couple to both cell proliferation and apoptosis. J Clin Invest 109:437-441
12. Chattergoon MA, Muthumani K, Tamura Y, Ramanathan M, Shames JP, Saulino V, Robinson TM, Montaner LJ, Weiner DB (2008) DR5 activation of caspase-8 induces DC maturation and immune enhancement in vivo. Mol Ther 16:419-426
13. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L (1997) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 7:821-830
14. Chen B, Ma B, Yang S, Xing X, Gu R, Hu Y (2009) DR5 and DcR2 are expressed in human lumbar intervertebral discs. Spine 34:E677-E681
15. Clarke RB (2006) Ovarian steroids and the human breast: regulation of stem cells and cell proliferation. Maturitas 54:327-334
16. Falschlehner C, Ganten TM, Koschny R, Schaefer U, Walczak H (2009) TRAIL and other TRAIL receptor agonists as novel cancer therapeutics. Adv Exp Med Biol 647:195-206
17. Harrison DC, Roberts J, Campbell CA, Crook B, Davis R, Deen K, Meakin J, Michalovich D, Price J, Stammers M, Maycox PR (2000) TR3 death receptor expression in the normal and ischaemic brain. Neuroscience 96:147-160
18. Henson ES, Johnston JB, Gibson SB (2008) The role of TRAIL death receptors in the treatment of hematological malignancies. Leuk Lymphoma 49:27-35
19. Huang Y, Jin H, Liu Y, Zhou J, Ding J, Cheng KW, Yu Y, Feng Y (2010) FSH inhibits ovarian cancer cell apoptosis by upregulating survivin and down-regulating PDCD6 and DR5. Endocr Relat Cancer 18:13-26
20. Hymowitz SG, Christinger HW, Fuh G, Ultsch M, O'Connell M, Kelley RF, Ashkenazi A, de Vos AM (1999) Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4:563-571
21. Ikeda T, Hirata S, Fukushima S, Matsunaga Y, Ito T, Uchino M, Nishimura Y, Senju S (2010) Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells. J Immunol 185:5259-5267
22. Imayoshi I, Sakamoto M, Ohtsuka T, Kageyama R (2009) Continuous neurogenesis in the adult brain. Dev Growth Differ 51: 379-386
23. Lan YH, Wu YC, Wu KW, Chung JG, Lu CC, Chen YL, Wu TS, Yang JS (2011) Death receptor 5-mediated TNFR family signaling pathways modulate c-humulene-induced apoptosis in human colorectal cancer HT29 cells. Oncol Rep 25:419-424
24. Leithner K, Stacher E, Wurm R, Ploner F, Quehenberger F, Wohlkoenig C, Bálint Z, Polachova J, Olschewski A, Samonigg H (2009) Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy. Lung Cancer 65:98-104
25. Lepage C, Léger DY, Bertrand J, Martin F, Beneytout JL, Liagre B (2011) Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells. Cancer Lett 301:193-202
26. Lin CW, Manshouri T, Jilani I, Neuberg D, Patel K, Kantarjian H, Andreeff M, Estrov Z, Beran M, Keating M (2002) Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome. Leuk Res 26:551-559
27. Lin SC, Lo YC, Wu H (2010) Helical assembly in the MyD88- IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465: 885-890
28. Loreto C, Almeida LE, Migliore MR, Caltabiano M, Leonardi R (2010) TRAIL, DR5 and caspase 3-dependent apoptosis in vessels of diseased human temporomandibular joint disc. An immunohistochemical study. Eur J Histochem 54:e40
29. Lossi L, Alasia S, Salio C, Merighi A (2009) Cell death and proliferation in acute slices and organotypic cultures of mammalian CNS. Prog Neurobiol 88:221-245
30. MacFarlane M (2003) TRAIL-induced signalling and apoptosis. Toxicol Lett 139:n89-n97
31. Maduro JH, Noordhuis MG, ten Hoor KA, Pras E, Arts HJ, Eijsink JJ, Hollema H, Mom CH, de Jong S, de Vries EG (2009) The prognostic value of TRAIL and its death receptors in cervical cancer. Int J Radiat Oncol Biol Phys 75:203-211
32. Mahalingam D, Szegezdi E, Keane M, Jong S, Samali A (2009) TRAIL receptor signalling and modulation: are we on the right TRAIL? Cancer Treat Rev 35:280-288
33. Mongiat LA, Schinder AF (2011) Adult neurogenesis and the plasticity of the dentate gyrus network. Eur J Neurosci 33: 1055-1061
34. Mori H, Sugie S, Yoshimi N, Hara A, Tanaka T (1999) Control of cell proliferation in cancer prevention. Mutat Res 428:291-298
35. Ohtsuki T, Kikuchi H, Koyano T, Kowithayakorn T, Sakai T, Ishibashi M (2009) Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis. Bioorg Med Chem 17:6748-6754
36. Oldenhuis CN, Stegehuis JH, Walenkamp AM, de Jong S, de Vries EG (2008) Targeting TRAIL death receptors. Curr Opin Pharmacol 8:433-439
37. Ozawa F, Friess H, Kleeff J, Xu ZW, Zimmermann A, Sheikh MS, Büchler MW (2001) Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. Cancer Lett 163:71-81
38. Pakala R, Pakala R, Sheng WL, Benedict CR (1999) Serotonin fails to induce proliferation of endothelial cells preloaded with eicosapentaenoic acid and docosahexaenoic acid. Atherosclerosis 145:137-146
39. Park SJ, Bijangi-Vishehsaraei K, Safa AR (2010) Selective TRAILtriggered apoptosis due to overexpression of TRAIL death receptor 5 (DR5) in P-glycoprotein-bearing multidrug resistant CEM/VBL1000 human leukemia cells. Int J Biochem Mol Biol 1:90-100
40. Peng H, Huang Y, Duan Z, Erdmann N, Xu D, Herek S, Zheng J (2005) Cellular IAP1 regulates TRAIL-induced apoptosis in human fetal cortical neural progenitor cells. J Neurosci Res 82:295-305
41. Sloviter RS (2002) Apoptosis: a guide for the perplexed. Trends Pharmacol Sci 23:19-24
42. Spierings DC, de Vries EG, Vellenga E, van den Heuvel FA, Koornstra JJ, Wesseling J, Hollema H, de Jong S (2004) Tissue distribution of the death ligand TRAIL and its receptors. J Histochem Cytochem 52:821-831
43. Szegezdi E, O'Reilly A, Davy Y, Vawda R, Taylor DL, Murphy M, Samali A, Mehmet H (2009) Stem cells are resistant to TRAIL receptor-mediated apoptosis. J Cell Mol Med 13:4409-4414
44. Takeda K, Kojima Y, Ikejima K, Harada K, Yamashina S, Okumura K, Aoyama T, Frese S, Ikeda H, Haynes NM (2008) Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease. Proc Natl Acad Sci USA 105:10895-10900
45. Tang W, Wang W, Zhang Y, Liu S, Liu Y, Zheng D (2009) TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent manner. Cell Res 19:758-767
46. Thoolen B (1990) BrdUrd labeling of S-phase cells in testes and small intestine of mice, using microwave irradiation for immunogoldsilver staining: an immunocytochemical study. J Histochem Cytochem 38:267-273
47. Whitman MC, Greer CA (2009) Adult neurogenesis and the olfactory system. Prog Neurobiol 89:162-175
48. Wu GS (2009) TRAIL as a target in anti-cancer therapy. Cancer Lett 285:1-5
49. Zhang Y, Zhang B (2008) TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Mol Cancer Res 6:m1861-m1871
50. Zhang Y, Niu B, Yu D, Cheng X, Liu B, Deng J (2010) Radial glial cells and the lamination of the cerebellar cortex. Brain Struct Funct 215:115-122